Shujun Xia

Dr. Shujun Xia


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2017 in BMC Neurology
Verified
Journal Article
Open access
PDF file
SXShujun Xia
Shujun Xia
RJRi Ji
Ri Ji
WZWei wei Zhan
Wei wei Zhan
The dysregulation of long noncoding RNAs (lncRNAs) has been identified in a variety of cancers. An increasing number of studies have found the critical role of lncRNAs in the regulation of cellular processes, such as proliferation, invasion and differentiation. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) is a novel lncRNA that was primarily detected in papillary thyroid carcinoma. However, the biological function and molecular mechanism of lncRNA PTCSC3 in glioma are still unknown. The expression level of lncRNA PTCSC3 in human microglia and glioma cell lines was examined using quantitative real-time polymerase chain reaction (qRT-PCR). The influence of lncRNA PTCSC3 on cell proliferation were studied using the cell counting kit-8, and cell cycle and apoptosis were analyzed by flow cytometry assays. The migration and invasion abilities were investigated by transwell and wound healing assays. The target genes of lncRNA PTCSC3 were explored by qRT-PCR, immunofluorescence and western blot. LncRNA PTCSC3 was significantly downregulated in glioma cell lines. The overexpression of lncRNA PTCSC3 suppressed proliferation and induced apoptosis in U87 and U251 cells. Additionally, the overexpression of lncRNA PTCSC3 inhibited the migration and invasion of U87 and U251 cells. Moreover, lncRNA PTCSC3 inhibited the epithelial-mesenchymal transition of U87 cells. The study also demonstrated that LRP6, as a receptor of the Wnt/β-catenin pathway, was a target of lncRNA PTCSC3. By evaluating the expression levels of Axin1, active β-catenin, c-myc, and cyclin D1, the study indicated that lncRNA PTCSC3 inhibited the activation of the Wnt/β-cateninpathway through targeting LRP6. LncRNA PTCSC3 inhibits the proliferation and migration of glioma cells and suppresses Wnt/β-catenin signaling pathway by targeting LRP6. LncRNA PTCSC3 is a potential therapeutic target for treatment of glioma.

27 September 2011 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
LXLei Xiang
Lei Xiang
PSPeng Su
Peng Su
SXShujun Xia
Shujun Xia
ZLZhiyan Liu
Zhiyan Liu
YWYan Wang
Yan Wang
GZGenyin Zhou
Genyin Zhou
Background: ABCG2 is an ABC transporter. It has been demonstrated that endogenous ABCG2 expression in certain cancers is a possible reflection of the differentiated phenotype of the cell of origin and likely contributes to intrinsic drug resistance. But little is known about the contribution of ABCG2 to the drug resistance and the clinicopathological characteristics in breast cancer. In the present study, we investigated the expression of ABCG2 and the correlations between ABCG2 expression and patients' clinicopathological and biological characteristics. Methods: Immunohistochemistry was employed on the tissue microarray paraffin sections of surgically removed samples from 196 breast cancer patients with clinicopathological data. Results: The results showed that ABCG2 was expressed in different intensities and distributions in the tumor cells of the breast invasive ductal carcinoma. A positive stain for ABCG2 was defined as a brown stain observed in the cytoplasm and cytomembrane. A statistically significant correlation was demonstrated between ABCG2 expression and HER-2 expression (p = 0.001), lymph node metastasis (p = 0.049), and clinical stage (p = 0.015) respectively. Conclusion: ABCG2 correlated with Her-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma. It could be a novel potential bio-marker which can predict biological behavior, clinical progression, prognosis and chemotherapy effectiveness.

1 January 2024 in Research
Verified
Journal Article
Open access
JXJiaLe Xu
JiaLe Xu
QHQing Hua
Qing Hua
XJXiaoHong Jia
XiaoHong Jia
YZYuHang Zheng
YuHang Zheng
QHQiao Hu
Qiao Hu
JZJianqiao Zhou
Jianqiao Zhou
The vast potential of medical big data to enhance healthcare outcomes remains underutilized due to privacy concerns, which restrict cross-center data sharing and the construction of diverse, large-scale datasets. To address this challenge, we developed a deep generative model aimed at synthesizing medical data to overcome data sharing barriers, with a focus on breast ultrasound (US) image synthesis. Specifically, we introduce CoLDiT, a conditional latent diffusion model with a transformer backbone, to generate US images of breast lesions across various Breast Imaging Reporting and Data System (BI-RADS) categories. Using a training dataset of 9,705 US images from 5,243 patients across 202 hospitals with diverse US systems, CoLDiT generated breast US images without duplicating private information, as confirmed through nearest-neighbor analysis. Blinded reader studies further validated the realism of these images, with area under the receiver operating characteristic curve (AUC) scores ranging from 0.53 to 0.77. Additionally, synthetic breast US images effectively augmented the training dataset for BI-RADS classification, achieving performance comparable to that using an equal-sized training set comprising solely real images ( P = 0.81 for AUC). Our findings suggest that synthetic data, such as CoLDiT-generated images, offer a viable, privacy-preserving solution to facilitate secure medical data sharing and advance the utilization of medical big data.

6 March 2025 in European Radiology
Verified
Journal Article
Closed access
PDF file
QHQing Hua
Qing Hua
YSYanYan Song
YanYan Song
WZWei Zhou
Wei Zhou
ZLZhenHua Liu
ZhenHua Liu
LZLu Zhang
Lu Zhang
JZJianqiao Zhou
Jianqiao Zhou

26 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YDYanran Du
Yanran Du
CJChao Ji
Chao Ji
JXJiale Xu
Jiale Xu
MWMinyan Wei
Minyan Wei
YRYunyun Ren
Yunyun Ren
JZJianqiao Zhou
Jianqiao Zhou
To evaluate and compare the performance of publicly available ChatGPT-3.5, ChatGPT-4.0 and Microsoft Copilot in Bing (Copilot) in answering obstetric ultrasound questions and analyzing obstetric ultrasound reports. Twenty questions related to obstetric ultrasound were answered and 110 obstetric ultrasound reports were analyzed by ChatGPT-3.5, ChatGPT-4.0 and Copilot, with each question and report being posed three times to them at different times. The accuracy and consistency of each response to twenty questions and each analysis result in the report were evaluated and compared. In answering twenty questions, both ChatGPT-3.5 and ChatGPT-4.0 outperformed Copilot in accuracy (95.0% vs. 80.0%) and consistency (90.0% and 85.0% vs. 75.0%). However, no statistical difference was found among them. When analyzing obstetric ultrasound reports, ChatGPT-3.5 and ChatGPT-4.0 demonstrated superior accuracy compared to Copilot (P < 0.05), and all three showed high consistency and the ability to provide recommendations. The overall accuracy and consistency of ChatGPT-3.5, ChatGPT-4.0, and Copilot were 83.86%, 84.13% vs. 77.51% in accuracy, and 87.30%, 93.65% vs. 90.48% in consistency, respectively. These large language models (ChatGPT-3.5, ChatGPT-4.0 and Copilot) have the potential to assist clinical workflows by enhancing patient education and patient clinical communication around common obstetric ultrasound issues. With inconsistent and sometimes inaccurate responses, along with cybersecurity concerns, physician supervision is crucial in the use of these models.

7 December 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
QWQingmin Wang
Qingmin Wang
XJXiaohong Jia
Xiaohong Jia
TLTing Luo
Ting Luo
JYJinhua Yu
Jinhua Yu
SXShujun Xia
Shujun Xia
Background: Ultrasonography is an important imaging method for clinical breast cancer screening. As the original echo signals of ultrasonography, ultrasound radiofrequency (RF) signals provide abundant tissue macroscopic and microscopic information and have important development and utilization value in breast cancer detection.Methods: In this study, we proposed a deep learning method based on bispectrum analysis feature maps to process RF signals and realize breast cancer detection. The bispectrum analysis energy feature maps with frequency subdivision were first proposed and applied to breast cancer detection in this study. Our deep learning network was based on a weight sharing network framework for the input of multiple feature maps. A feature map attention module was designed for multiple feature maps input of the network to adaptively learn both feature maps and features that were conducive to classification. We also designed a similarity constraint factor, learning the similarity and difference between feature maps by cosine distance.Results: The experiment results showed that the areas under the receiver operating characteristic curves of our proposed method in the validation set and two independent test sets for benign and malignant breast tumor classification were 0.913, 0.900, and 0.885, respectively. The performance of the model combining four ultrasound bispectrum analysis energy feature maps in breast cancer detection was superior to that of the model using an ultrasound grayscale image and the model using a single bispectrum analysis energy feature map in this study.Conclusion: The combination of deep learning technology and our proposed ultrasound bispectrum analysis energy feature maps effectively realized breast cancer detection and was an efficient method of feature extraction and utilization of ultrasound RF signals.